Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I. Shaw, Jessica Wagner, Liqing Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade glioma
Priyanka Sehgal, Ammar S. Naqvi, Mary Higgins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme
Xi Liu, Jinming Song, Zhiming Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Steering research on mRNA splicing in cancer towards clinical translation
Olga Anczuków, Frédéric H.‐T. Allain, Brittany Angarola, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 887-905
Closed Access | Times Cited: 4
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors
Elizabeth Wickman, Shannon Lange, Jessica Wagner, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009743-e009743
Open Access | Times Cited: 3
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis
Huili Pan, Zhiyan Luo, Lin Feng, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapy
Rawan Shraim, Brian Mooney, Karina L. Conkrite, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors
Stephen C. Frederico, Itay Raphael, Michal Nisnboym, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1411-1420
Closed Access
Unveiling the molecular interplay between a novel chromene derivative and DNA: a multifaceted investigation
Dipak Kumar Sahoo, Nilima Priyadarsini Mishra, Shamasoddin Shekh, et al.
Chemical Papers (2024) Vol. 78, Iss. 14, pp. 8045-8057
Closed Access
CAR T-cells for pediatric solid tumors: where to go from here?
Tina Trautmann, Natalia Yakobian, Rosa Nguyen
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1445-1461
Open Access
Targeting splicing for hematological malignancies therapy
Monika Szelest, Krzysztof Giannopoulos
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors
Yuqing Luo, Jianqiao Shentu, Hening Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Page 1

Scroll to top